This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Other. Active years: 2010.
Company Filing History:
1 out of 834,307 Years Active: 2010
Title: Matilde Todaro: Innovator in Cancer Research
Introduction
Matilde Todaro is a prominent inventor based in Palermo, Italy. She has made significant contributions to the field of cancer research, particularly in the area of apoptosis and cytokine modulation. Her innovative work has the potential to impact the treatment of drug-resistant cancer cells.
Latest Patents
Matilde Todaro holds a patent for her invention titled "Sensitizing cells for apoptosis by selectively blocking cytokines." This invention involves the use of a cytokine antagonist that modulates the expression and function of a Th2 helper cell cytokine. The modulation leads to the down-regulation of anti-apoptotic proteins in cells, sensitizing them for apoptosis. This approach is particularly relevant for treating drug-resistant cancer cells that fail to undergo apoptosis.
Career Highlights
Throughout her career, Matilde has worked with various organizations, including Apogenix GmbH. Her research focuses on the intersection of immunology and oncology, aiming to develop novel therapeutic strategies for cancer treatment.
Collaborations
Matilde has collaborated with notable professionals in her field, including Giorgio Stassi and Oliver Hill. These partnerships have enhanced her research and contributed to the advancement of cancer therapies.
Conclusion
Matilde Todaro's innovative work in cancer research exemplifies the importance of scientific advancements in the fight against cancer. Her contributions, particularly in the modulation of cytokines, hold promise for improving treatment outcomes for patients with drug-resistant cancers.